Bert Slonim concentrates on complex commercial litigation, particularly
multi-district pharmaceutical product liability cases. He has
represented manufacturers of prescription drugs (Hormone Replacement
Therapy, Viagra, Rezulin, Trovan, anti-psychotics and others),
implanted medical devices (artificial heart valves and erectile
dysfunction devices), agricultural chemicals, electrical equipment,
aerospace products, asbestos and other products. Much of his practice
focuses on developing and rebutting expert medical and scientific
evidence, and litigating the admissibility of expert opinion testimony.
MORE
MORE
Mr. Slonim also has significant experience in antitrust cases,
including a Supreme Court case that established the antitrust
boundaries of private code and standard-making activities. Other
litigation experience includes managed care disputes (antitrust and
contract), third-party payor claims, unfair competition, commercial
contracts and false advertising.
Prior to joining Kaye Scholer, Mr. Slonim was a trial attorney with the Federal Trade Commission's Bureau of Competition, where he worked on merger, monopolization and price-fixing litigations.
Mr. Slonim also taught legal research and writing as a Teaching Fellow at Stanford Law School.
Prior to joining Kaye Scholer, Mr. Slonim was a trial attorney with the Federal Trade Commission's Bureau of Competition, where he worked on merger, monopolization and price-fixing litigations.
Mr. Slonim also taught legal research and writing as a Teaching Fellow at Stanford Law School.